ASSOCHAM projects India pharma market at USD 120–130 billion by 2030 EP News Bureau Jun 11, 2026 Knowledge paper outlines growth drivers, biosimilars opportunity and priorities for India Pharma 2030
Demystifying pharma science: Batch v/s continuous manufacturing – choosing the right approach Indu Bhushan Jun 1, 2024 By Indu Bhushan, CEO & Director, STEERLife
